Atlas Trials

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Clinical trial NCT00434174 · COMPLETED

Trial details

NCT number
NCT00434174
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2006-12-01
Primary completion
2010-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.